Immunogenicity of the associated administration of Evanovo® and a commercial HVT–ND–IBD vaccine in commercial broiler chickens Prevalence of the new IBDV strain UK2019 in slow-growing broilers in the Netherlands Clinical safety and efficacy of in-ovo coadministration of a new vaccine against avi...
The most common diseases are Fowl pox, Fowl cholera, Fowl typhoid (FT), mycoplasmosis, Blue comb/blackhead, and roundworm infections. Blackhead is an asymptomatic disease in chicken but can cause mortality in turkey flocks. Hence, it is generally recommended that turkey poults and chicks as wel...
Summary Live fowl pox (FP) vaccine was adjuvanted in oil just prior to the subcutaneous (SC) vaccination of one day old chicks and adult chickens. The birds were challenged by the wing web (WW) method and absence of "takes" were considered as protection. On 21 day post challenge, 90 %...
A commercial fowl pox vaccine was used for the vaccination of six-week old turkeys by means of three different administration methods: single and double wing web stick and follicle infection. No difference between these methods could be observed as far as the protection was concerned. The single...
Fowl pox: Fowl pox is a viral infection caused by large DNA virus (an avipoxvirus in the Poxviridae family) that may survive in the environment for extended periods in dried scabs. Nodular lesions on unfeathered skin are common in the cutaneous form. In the diphtheritic form, which affects...
Administration of live fowl pox vaccine in White Leghorn breeder birds along with Stresroak and Levarnisole treatment enahanced the level of antibody production significantly. The transfer of passive antibody (maternal antibody) from immune breeders to theprogeny chicks were also significantly higher ...
[14,15]. With the advancements of reverse genetic technology and gene editing, several viruses have been successfully modified into viral vectors, including adenovirus [16], pox- virus [17], etc. Adenovirus vectors are widely applied in gene therapy [18], as well as in vaccine development ...